XWPharma: Clinical Trials

1 trial sponsored by XWPharma, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 withdrawn. 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 21Withdrawn 1

Follow XWPharma: new trials by email

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Valiloxybate (XW10172 MR) Efficacy and Safety Parkinson's Disease Study
Valiloxybate, Placebo - Parkinson Disease, Excessive Daytime Somnolence
Phase 2WithdrawnXWPharma2021-11-012025-03-19

Conditions studied

Disorders of Excessive Somnolence (1)  ·  Parkinson Disease (1)

Top investigators

Daniel M. Canafax, PharmD (1)